Literature DB >> 11855570

Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Marie T Bakowski, Philip Prescott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855570     DOI: 10.1023/a:1013715415778

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Authors:  H Allgayer; P Böhne; W Kruis
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Authors:  M L Borum; A L Ginsberg
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

3.  Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.

Authors:  M T Bakowski; P Prescott
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-09       Impact factor: 2.890

Review 4.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.

Authors:  P Prescott; M T Bakowski
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-10       Impact factor: 2.890

Review 6.  Colonic strictures induced by nonsteroidal anti-inflammatory drugs.

Authors:  A Ribeiro; H C Wolfsen; J T Wolfe; D S Loeb
Journal:  South Med J       Date:  1998-06       Impact factor: 0.954

7.  Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Authors:  R L Smyth; D van Velzen; A R Smyth; D A Lloyd; D P Heaf
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.